Liabilities, Current in USD of Calidi Biotherapeutics, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Calidi Biotherapeutics, Inc. quarterly Liabilities, Current history and change rate from Q3 2021 to Q3 2025.
  • Calidi Biotherapeutics, Inc. Liabilities, Current for the quarter ending September 30, 2025 was $5.19M, a 55.2% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Calidi Biotherapeutics, Inc. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $5.19M -$6.39M -55.2% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $5.35M -$7.7M -59% Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $5.43M -$9.53M -63.7% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $9.5M -$736K -7.19% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 $11.6M +$706K +6.49% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $13.1M +$4.87M +59.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $15M +$8.34M +126% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $10.2M -$32.8M -76.2% Dec 31, 2023 10-K 2025-03-31
Q3 2023 $10.9M +$9.53M +712% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $8.18M +$7.81M +2090% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $6.62M +$6.23M +1610% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $43M +$42.6M +10360% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $1.34M +$1.29M +2697% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $374K Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $387K Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $411K Dec 31, 2021 10-K 2023-03-31
Q3 2021 $47.9K Sep 30, 2021 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.